Segment Reporting (Tables)

3 Months Ended

Nov. 30, 2016

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated

The following table reflects results of operations of the Company’s reportable segments (in millions):

	Retail Pharmacy USA		Retail Pharmacy International		Pharmaceutical Wholesale		Eliminations			Walgreens Boots Alliance, Inc.
Three Months Ended November 30, 2016
Sales to external customers	$	20,659	$	2,962	$	4,880	$	-		$	28,501
Intersegment sales		-		-		537		(537	)		-
Sales	$	20,659	$	2,962	$	5,417	$	(537	)	$	28,501
Adjusted Operating Income	$	1,289	$	213	$	224	$	-		$	1,726
Three Months Ended November 30, 2015
Sales to external customers	$	20,370	$	3,459	$	5,204	$	-		$	29,033
Intersegment sales		-		-		592		(592	)		-
Sales	$	20,370	$	3,459	$	5,796	$	(592	)	$	29,033
Adjusted Operating Income	$	1,243	$	315	$	166	$	(5	)	$	1,719

Reconciliation of Operating Income (Loss) from Segments to Consolidated

The following table reconciles adjusted operating income to operating income (in millions):

	Retail Pharmacy USA		Retail Pharmacy International		Pharmaceutical Wholesale		Eliminations			Walgreens Boots Alliance, Inc.
Three Months Ended November 30, 2016
Adjusted Operating Income	$	1,289	$	213	$	224	$	-		$	1,726
Acquisition-related amortization											(82	)
Cost transformation											(81	)
LIFO provision											(58	)
Adjustments to equity earnings in AmerisourceBergen											(41	)
Acquisition-related costs											(17	)
Operating Income										$	1,447
Three Months Ended November 30, 2015
Adjusted Operating Income	$	1,243	$	315	$	166	$	(5	)	$	1,719
Acquisition-related amortization											(81	)
Cost transformation											(90	)
LIFO provision											(46	)
Acquisition-related costs											(34	)
Operating Income										$	1,468